Related Experiment Video
Updated: May 25, 2025

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
Systemic Therapy and Surgical Management of Peritoneal Mesothelioma
Ricardo E Nunez-Rocha1, Alex C Kim2, Mohamed Adam3
1Department of Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. Electronic address: https://twitter.com/mohamedadam.
Abstract:
Malignant peritoneal mesothelioma is an aggressive and rare disease that affects the serosal membranes. The outcomes of patients who suffer from this disease have improved because of the advances in imaging, genetics, and treatment strategies such as systemic therapy and cytoreduction surgery and hyperthermic intraperitoneal chemotherapy. Multidisciplinary care remains essential for enhancing survival and quality of life.
Related Concept Videos
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Pleural Disorders: Types and Brief Description
Chronic Pancreatitis II: Collaborative Care
Assessment:

